Left ventricular hypertrophy (LVH) in hypertensive heart disease promots the occurrence of atrial and ventricular arrhythmias exposing the hemodynamic and embolic risk. The aim of our study was to evaluate the prevalence of cardiac arrhythmias in this population and to offer suitable support. This is a prospective, analytical study of 13 months including 186 hypertensive patients with and without LVH hypertensive. We placed these patients a 24-hour holter electrocardiography. We excluded all patients with other types of heart disease and those taking beta-blocker treatment and / or antiarrhythmic. The average age of our patients was 63 ± 6 years with female predominance. 59% of patients with LVH showed heart rhythm disorders versus 7% of patients without LVH. Ventricular premature beats occurred in 21.1% with LVH versus 4.1% without LVH, nonsustained ventricular tachycardia in 2.4% with LVH against 0,4% without LVH, the supraventricular extrasystoles occurred in 57.2% with LVH against 14.1%. ACFA and atrial tachycardia in 11.7% with LVH versus 1.3%. The variability of the heart rate was altered in 35,4% with LVH versus 6.8% without LVH. Arrhythmias represent the third face of hypertensive heart disease after coronary artery disease and heart failure. Holter ECG recording information on the three factors of atrial or ventricular arrhythmias: the trigger, the state of the autonomic nervous system and the search for silent ischemia. An early and effective management of hypertension is necessary to prevent the onset or regress left ventricular hypertrophy, determining factor in the genesis of these arrhythmias. The author hereby declares no conflict of interest